CARBOPLATINE TEVA 10 mg/ml
Sponsors
Institut Curie
Conditions
Retinoblastoma
Phase 2
RB SFCE 2009 : Adjuvant treatment in extensive unilateral retinoblastoma primary enucleated
Active, not recruitingCTIS2024-514844-10-00
Start: 2010-03-18Target: 195Updated: 2025-07-01
"RETINO 2011" : Conservative treatment of patients with retinoblastoma
RecruitingCTIS2024-517275-21-00
Start: 2012-02-20Target: 133Updated: 2024-09-05